147P Genomic profile and response prediction of eribulin mesylate-based neoadjuvant chemotherapy in triple-negative breast cancer patients
| Autor: | Nishimura, T., Masuda, N., Kawaguchi, K., Takada, M., Maeshima, Y., Tanaka, S., Velaga, R., Kikawa, Y., Kadoya, T., Bando, H., Nakamura, R., Yamamoto, Y., Ueno, T., Yasojima, H., Ishiguro, H., Morita, S., Ohno, S., Haga, H., Ogawa, S., Toi, M. |
|---|---|
| Zdroj: | In Annals of Oncology September 2021 32 Supplement 5:S424-S425 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|